Intended for healthcare professionals

CCBYNC Open access
Research

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

BMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n1205 (Published 09 June 2021) Cite this as: BMJ 2021;373:n1205